Three Anavex Directors Resign Over Strategic Differences

• Anavex Life Sciences board chair Jiong Ma, Gautam Patel and Adrian Senderowicz resigned effective October 28, 2026.
• All three cited differences with the board and management over company strategy.
• On November 1, 2026, the audit committee was reconstituted with Claus van der Velden as chair alongside Peter Donhauser and Axel Paeger.
• The nominating and corporate governance committee was reconstituted on the same date, with Paeger as chair alongside Donhauser.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anavex Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001731122-26-001392), on November 02, 2026, and is solely responsible for the information contained therein.